Category: Drug Safety Alerts
-
Adderall and Ritalin: With Heart Risks Uncertain, What Should Patients Do?
Some Medical Advice About ADHD/ADD Drugs From Cardiologists And Psychiatrists In mid-February 2006 came the news that an advisory panel of drug-safety experts recommended a "black-box" warning for Adderall, Ritalin, and the other ADHD/ADD…
-
Study Shows Blood-Clot Risk For Birth Control Patch Is Double That Of An Oral Contraceptive
However, According To Another Study Ortho Evra Skin Patch Use Presents No Increased Risk Of Blood Clots On February 16, 2006 Ortho-McNeil Pharmaceutical, Inc., a Johnson & Johnson (J&J) unit, announced that some preliminary…
-
Adderall Safety Is Not Proven By Health Canada’s Decision To Reverse Ban On ADHD Drug
A Closer Look At How (Or Why) Adderall Got Back On The Market In Canada In the October 7, 2005 edition of Psychiatric News there was an article by Jim Rosack entitled "Canada Reverses…
-
“Black-box” Warnings Are Forgotten Or Ignored By Some Doctors
The So-called Black Box Is FDA’s Highest Form Of Drug Safety Alert In the February 14, 2006 edition of the medical journal Archives of Internal Medicine there is a report that many patients are…
-
Health Canada Warning: Possible Link Between Ketek And Liver Failure
Reports Of Hepatitis And Serious Liver Problems Involving Ketek Use On February 7, 2006 Health Canada issued a Warning about the antibiotic Ketek and its possible association with potentially serious liver problems. According to…
-
Ortho Evra Birth Control Patch Linked To Increased Risk of Serious Blood Clots
2005 Label Change Warns About Higher Levels Of Estrogen Found In Ortho Evra In July 2005 the Associated Press (AP) published an investigative article that linked the birth control patch Ortho Evra to an…
-
February 2006 FDA “Patient Safety News” Videos For Doctors Online
Edition Covers Alpha-1 Blockers, Amevive, Salagen – Selegiline Name Confusion, and More The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily for doctors and other health care…
-
European Union’s Drug Regulator Requests Stronger Warnings On Antibiotic Ketek
EMEA Action Follows Reports of Ketek-related Liver Problems In U.S. The European Medicines Agency (EMEA) said in a January 27, 2006 statement that it had asked Sanofi-Aventis to include stronger warnings on Ketek about…
-
Reports Of Liver Problems Associated With Antibiotic Ketek
Three NC Hospital Cases Subject Of Article In Annals Of Internal Medicine On January 20, 2006 the Annals of Internal Medicine published online an "early" release version of an article describing liver problems associated…
-
Elidel And Protopic Will Finally Get Black-box Warnings
FDA: Eczema Products Must Warn About Increased Cancer Risks On January 19, 2006 the FDA announced that two eczema products, Elidel and Protopic, must have a "black-box" warning placed on their package insert, or…